Lessons from the Mainland of China’s Epidemic Experience in the First Phase about the Growth Rules of Infected and Recovered Cases of COVID-19 Worldwide

Author:

Han Chuanliang,Liu Yimeng,Tang Jiting,Zhu Yuyao,Jaeger Carlo,Yang Saini

Abstract

AbstractThe first phase of the novel coronavirus disease (COVID-19) that emerged at the end of 2019 has been brought under control in the mainland of China in March, while it is still spreading globally. When the pandemic will end is a question of great concern. A logistic model that depicts the growth rules of infected and recovered cases in China’s mainland may shed some light on this question. This model well explained the data by 13 April from 31 countries that have been experiencing serious COVID-2019 outbreaks (R2 ≥ 0.95). Based on this model, the semi-saturation period (SSP) of infected cases in those countries ranges from 3 March to 18 June. According to the linear relationship between the growth rules for infected and for recovered cases identified from the Chinese data, we predicted that the SSP of the recovered cases outside China ranges from 22 March to 8 July. More importantly, we found a strong positive correlation between the SSP of infected cases and the timing of a government’s response. Finally, this model was also applied to four regions that went through other coronavirus or Ebola virus epidemics (R2 ≥ 0.95). There is a negative correlation between the death rate and the logistic growth rate. These findings provide strong evidence for the effectiveness of rapid epidemic control measures in various countries.

Publisher

Springer Science and Business Media LLC

Subject

Management, Monitoring, Policy and Law,Safety Research,Geography, Planning and Development,Global and Planetary Change

Reference29 articles.

1. Abdi, M. 2020. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infection Control & Hospital Epidemiology 41(6): 754–755.

2. Azman, A.S., and F.J. Luquero. 2020. From China: Hope and lessons for COVID-19 control. The Lancet Infectious Diseases 20(7): 756–757.

3. CCDC (Chinese Center for Disease Control and Prevention). 2020a. The latest situation of COVID-19. Beijing: CCDC. http://www.nhc.gov.cn/xcs/yqtb/202003/9d462194284840ad96ce75eb8e4c8039.shtml. Accessed 29 Feb 2020 (in Chinese).

4. CCDC (Chinese Center for Disease Control and Prevention). 2020b. Prevention and control measures of COVID-19. Beijing: CCDC. http://www.nhc.gov.cn/jkj/s3577/202002/a5d6f7b8c48c451c87dba14889b30147/files/3514cb996ae24e2faf65953b4ecd0df4.pdf. Accessed 29 Feb 2020 (in Chinese).

5. CCDC (Chinese Center for Disease Control and Prevention). 2020c. SARS. http://www.nhc.gov.cn/wjw/index.shtml. Accessed 29 Feb 2020 (in Chinese).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3